Free Module 5 · Prostate and urinary symptoms

Medical treatment of BPH

1

Introduction

What this lesson covers The choice of treatment depends on: symptom severity, impact on quality of life, prostate size, risk of progression, comorbidities, sexual function, and patient preferences.
2

Video lesson

▶
Video pending upload (embedded YouTube)
3

Summary

Mild or minimally bothersome symptoms

Watchful waiting may be used, accompanied by:

  • Education.
  • Lifestyle modification.
  • Reduction of nighttime fluids.
  • Moderation of caffeine and alcohol.
  • Clinical follow-up.

Alpha-blockers

Examples: tamsulosin, silodosin, alfuzosin, doxazosin, terazosin.

They act by reducing the tone of prostatic and urethral smooth muscle. They have a relatively rapid onset of action. They improve symptoms, but do not significantly reduce prostate size or, on their own, prevent progression.

⚠️ Relevant adverse effects

  • Tamsulosin and silodosin: ejaculatory disorders.
  • Doxazosin and terazosin: higher risk of orthostatic hypotension.
  • Some alpha-blockers are associated with intraoperative floppy iris syndrome.

5-alpha-reductase inhibitors

Examples: finasteride, dutasteride.

They decrease the conversion of testosterone to dihydrotestosterone. They progressively reduce prostate volume and lower the risk of:

  • Progression.
  • Urinary retention.
  • Need for surgery.

They are mainly used in patients with moderate or severe LUTS and an enlarged prostate at risk of progression. Their effect is slow and may take several months.

Tadalafil

Tadalafil 5 mg/day can improve LUTS and is especially useful when erectile dysfunction coexists.

🚫 Contraindication

It is contraindicated with nitrates.

Predominantly storage symptoms

In selected patients, the following may be used:

  • Antimuscarinics.
  • Beta-3 agonists.

The risk of retention and the postvoid residual must be assessed.

Combination therapy

An alpha-blocker + a 5-alpha-reductase inhibitor may be used in patients with:

  • Moderate or severe symptoms.
  • Enlarged prostate.
  • Higher risk of progression.

The combination improves symptoms and, in the long term, reduces the risk of urinary retention and surgery.

Quick choice

  1. Need for rapid symptom relief → alpha-blocker.
  2. Enlarged prostate + risk of progression → 5-ARI ± alpha-blocker.
  3. LUTS + erectile dysfunction → consider tadalafil.
  4. Predominance of storage symptoms → consider specific storage-symptom treatment.
4

PDF

Content pending upload There is no downloadable PDF for this lesson yet.
5

Practical algorithm

Content pending upload The "Quick choice" outline from the Summary (block 3) will be turned into a visual diagram here.
6

Clinical case

Integrative case

Man with lower urinary tract symptoms

Step-by-step case presentation — you make decisions as it unfolds, with a score and feedback at the end.

Solve the case →
7

Self-assessment

Questions pending upload 5–10 multiple-choice questions on this lesson.
8

References

Content pending upload The specific references for this lesson will be added.

Want us to let you know when this lesson is complete?

All set, we'll let you know! 🎉
← Back to program Next lesson: Surgical indications →